| RECIST标准评价食管癌新辅助化疗疗效的可行性研究 |
| |
| 引用本文： | 朱学庆,张从军,钱勇,陈振东.RECIST标准评价食管癌新辅助化疗疗效的可行性研究[J].安徽医药,2009,13(5):521-523. |
| |
| 作者姓名： | 朱学庆 张从军 钱勇 陈振东 |
| |
| 作者单位： | 安徽省铜陵市人民医院肿瘤内科,安徽,铜陵,244000;安徽医科大学第一附属医院肿瘤内科,安徽,合肥,230022 |
| |
| 基金项目： | 安徽省自然科学基金重点项目 |
| |
| 摘 要： | 目的探讨运用RECIST标准评价食管癌新辅助化疗疗效的可行性。方法选择新辅助化疗食管癌患者。根据食管钡餐X线片显示病变长度，将食管病灶分为T1、T2、乃、T4期，CT扫描确定N、M分期。FLP方案化疗2个周期后，按照RECIST标准评价食管癌化疗疗效。结果68例患者中，T1、T2、T3、T4期分别为2、31、24、11例，N0、N1期分别为12、56例。临床分期Ⅲ、Ⅳa及Ⅳb期分别为25、20、23例。化疗2个周期后评价疗效，CR1例，PR27例，SD30例，PD10例，RR为41％。结论RE-CIST标准能够评价食管癌新辅助化疗疗效，食管钡餐X线片显示病灶长度确定食管癌T分期，更适用于临床应用。
|
| 关 键 词： | 食管癌 临床分期 RECIST 新辅助化疗 |
Feasibility study on evaluation of neoadjuvant chemotherapeutic response of esophageal cancer with RECIST criteria |
| |
| ZHU Xue-qing,ZHANG Cong-jun,QING Yong,CHEN Zhen-dong.Feasibility study on evaluation of neoadjuvant chemotherapeutic response of esophageal cancer with RECIST criteria[J].Anhui Medical and Pharmaceutical Journal,2009,13(5):521-523. |
| |
| Authors: | ZHU Xue-qing ZHANG Cong-jun QING Yong CHEN Zhen-dong |
| |
| Institution: | ZHU Xue-qing1,ZHANG Cong-jun2,QING Yong2,CHEN Zhen-dong2(1.Department of Oncology,Tongling People\'s Hospital,Tongling 244000,China,2.Department of Oncology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022,China) |
| |
| Abstract: | Aim To assess the feasibility of the response of neoadjuvant chemotherapy in esophageal cancer with RECIST criteria.Methods The esophageal cancer patients with neoadjuvant chemotherapy were selected.According to barium meal X-ray film,the primary lesion lengths in esophagus were divided into T1,T2,T3 and T4.The N and M stage was determined by CT scan.The response was evaluated according to RECIST criteria after 2 cycles of chemotherapy of FLP regimen.Results There were 2 cases for T1,31 cases for T2,24 case... |
| |
| Keywords: | RECIST |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
